Literature DB >> 1855190

Risk factors for bilateral testicular germ cell tumors. Does heredity play a role?

C Kratzik1, P Aiginger, W Kuber, M Riccabona, I Kührer, H Joos, J Frick, G Amann, W Mayr.   

Abstract

Twenty-three bilateral testicular germ cell tumors (four synchronous and 19 sequential tumors) were investigated for potential risk factors. The incidence of maldescensus testis was not found to be higher than in patients with unilateral disease. The histologic findings of the first tumor did not have any effect on the incidence of the second tumor. In 21 patients (four synchronous and 17 sequential tumors), histocompatibility antigens (HLA) were determined; HLA-B14 was increased significantly in the sequential tumor group. Tendencies toward an increase of HLA-DR5 and HLA-DR7 also were found. The HLA-DR1, HLA-DR3, and HLA-DR4 showed a tendency toward a decreased frequency. Therefore genetic factors might be important in the development of sequential bilateral testicular cancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855190     DOI: 10.1002/1097-0142(19910815)68:4<916::aid-cncr2820680440>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Molecular mechanisms of testicular carcinogenesis.

Authors:  D B Rukstalis
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

2.  False-negative biopsy for testicular intraepithelial neoplasia.

Authors:  K P Dieckmann; F Kaup; V Loy
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Low-dose radiation therapy for testicular intraepithelial neoplasia.

Authors:  K P Dieckmann; A Besserer; V Loy
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 4.  Second cancer after treatment of malignant germ-cell tumors.

Authors:  S D Fosså; E H Wanderås; K Heimdal
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

5.  Sequential bilateral testicular tumours presenting with intervals of 20 years and more.

Authors:  Klaus-Peter Dieckmann; Petra Anheuser; Florentine Sattler; Tobias Von Kügelgen; Cord Matthies; Christian Ruf
Journal:  BMC Urol       Date:  2013-12-09       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.